Congestive heart failure history and symptoms: Difference between revisions

	Congestive Heart Failure Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Systolic Dysfunction Diastolic Dysfunction HFpEF HFrEF
Causes
Differentiating Congestive heart failure from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Clinical Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Cardiac MRI
Echocardiography
Exercise Stress Test
Myocardial Viability Studies
Cardiac Catheterization
Other Imaging Studies
Other Diagnostic Studies
Treatment
Invasive Hemodynamic Monitoring
Medical Therapy:
Summary
Acute Pharmacotherapy
Chronic Pharmacotherapy in HFpEF
Chronic Pharmacotherapy in HFrEF Diuretics ACE Inhibitors Angiotensin receptor blockers Aldosterone Antagonists Beta Blockers Ca Channel Blockers Nitrates Hydralazine Positive Inotropics Anticoagulants Angiotensin Receptor-Neprilysin Inhibitor Antiarrhythmic Drugs Nutritional Supplements Hormonal Therapies Drugs to Avoid Drug Interactions Treatment of underlying causes Associated conditions
Exercise Training
Surgical Therapy: Biventricular Pacing or Cardiac Resynchronization Therapy (CRT) Implantation of Intracardiac Defibrillator Ultrafiltration Cardiac Surgery Left Ventricular Assist Devices (LVADs) Cardiac Transplantation
ACC/AHA Guideline Recommendations Initial and Serial Evaluation of the HF Patient Hospitalized Patient Patients With a Prior MI Sudden Cardiac Death Prevention Surgical/Percutaneous/Transcather Interventional Treatments of HF Patients at high risk for developing heart failure (Stage A) Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B) Patients with current or prior symptoms of heart failure (Stage C) Patients with refractory end-stage heart failure (Stage D) Coordinating Care for Patients With Chronic HF Quality Metrics/Performance Measures
Implementation of Practice Guidelines
Congestive heart failure end-of-life considerations
Specific Groups: Special Populations Patients who have concomitant disorders Obstructive Sleep Apnea in the Patient with CHF NSTEMI with Heart Failure and Cardiogenic Shock
Congestive heart failure history and symptoms On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Congestive heart failure history and symptoms
CDC on Congestive heart failure history and symptoms
Congestive heart failure history and symptoms in the news
Blogs on Congestive heart failure history and symptoms
Directions to Hospitals Treating Congestive heart failure history and symptoms
Risk calculators and risk factors for Congestive heart failure history and symptoms

VisualWikitext

Latest revision as of 04:10, 10 February 2022

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

The classic symptoms of heart failure include dyspnea, fatigue, and fluid retention. Patients with heart failure present in different ways. Some patients present with exercise intolerance but show little evidence of congestion or edema. Other patients present with mild symptoms of edema and pulmonary congestion. The ejection fraction is usually below 35% in patients who are symptomatic with systolic heart failure.

Symptoms

Table bellow shows Symptoms and signs of heart failure:

Typical symptoms	More specific signs
Breathlessness Orthopnoea Paroxysmal nocturnal dyspnoea Reduced exercise tolerance Fatigue Tiredness Increased time to recover after exercise Ankle swelling	Elevated jugular venous pressure Hepatojugular reflux Third heart sound (gallop rhythm) Laterally displaced apical impulse
Less typical symptoms	Less specific signs
Nocturnal cough Wheezing Bloated feeling Loss of appetite Confusion (especially in the elderly) Depression Palpitation Dizziness Syncope Bendopnea	Weight gain (>2 kg/week) Weight loss (in advanced HF) Tissue wasting (cachexia) Cardiac murmur Peripheral oedema (ankle, sacral, scrotal) Pulmonary crepitations Pleural effusion Tachycardia Irregular pulse Tachypnoea Cheyne-Stokes respiration Hepatomegaly Ascites Cold extremities Oliguria Narrow pulse pressure

The above table adopted from 2021 ESC Guideline

^[1]

Symptoms of Left Sided Congestive Heart Failure

The left side pumps blood into the systemic circulation, while the right side pumps blood into the pulmonary circulation. Although left-sided heart failure will reduce forward cardiac output to the systemic circulation, the initial symptoms are often due to pulmonary congestion. In systolic dysfunction, the ejection fraction is decreased, leaving an abnormally elevated volume of blood in the left ventricle. In diastolic dysfunction, left ventricular end-diastolic pressure will be high. This increase in volume or pressure backs up to the left atrium and then into the pulmonary veins. Increased volume or pressure in the pulmonary veins impairs the normal drainage of the alveoli and favors the flow of fluid from the capillaries to the lung parenchyma, causing pulmonary edema. This impairs gas exchange and results in hypoxemia. Thus, left-sided heart failure often presents with respiratory symptoms including:

New York Heart Association Criteria (NYHA)

The following criteria are often used to gauge the severity of heart failure:

NYHA I: No symptoms with ordinary activity.

NYHA II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.

NYHA III: Marked limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.

NYHA IV: Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency present at rest.

References

↑ McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam C, Lyon AR, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano G, Ruschitzka F, Kathrine Skibelund A (September 2021). "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure". Eur Heart J. 42 (36): 3599–3726. doi:10.1093/eurheartj/ehab368. PMID 34447992 Check |pmid= value (help). Vancouver style error: initials (help)

Template:WikiDoc Sources

[pmid34447992-1] McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam C, Lyon AR, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano G, Ruschitzka F, Kathrine Skibelund A (September 2021). "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure". Eur Heart J. 42 (36): 3599–3726. doi:10.1093/eurheartj/ehab368. PMID 34447992 Check |pmid= value (help). Vancouver style error: initials (help)

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
+{| class="infobox" style="float:right;"
+|-
+| [[File:Siren.gif|30px|link= Heart failure resident survival guide]]|| <br> || <br>
+| [[Heart failure resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
+|}
 {{Congestive heart failure}}
 {{CMG}}; {{AOEIC}} {{LG}}
@@ Line 6: / Line 12: @@
 The classic symptoms of heart failure include [[dyspnea]], [[fatigue]], and [[fluid retention]]. Patients with heart failure present in different ways. Some patients present with [[exercise intolerance]] but show little evidence of [[congestion]] or [[edema]]. Other patients present with mild symptoms of [[edema]] and [[pulmonary congestion]]. The [[ejection fraction]] is usually below 35% in patients who are symptomatic with systolic heart failure.
-==Symptoms of Congestive Heart Failure==
+==Symptoms==
-* [[Ankle edema]] or [[swelling of the feet]] and legs
+* Table bellow shows [[Symptoms]] and [[sign]]s of [[heart failure]]:
-* [[Claudication]] or [[pain with walking]]
+{| style="border: 2px solid #4479BA; align="left"
-* [[Confusion]] and [[altered mentation]]
+! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF|Typical symptoms}}
-* [[Cool extremities]] or [[cold and clammy hands]]
+! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|More specific signs}}
-* [[Cyanosis]] or [[bluish color to the skin]]
+|-
-* [[Dizziness]]
+| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Breathlessness]]
-* [[Dyspnea|Dyspnea on ordinary exertion]] or greater shortness of breath with usual activities
+*[[Orthopnoea]]
-* [[Fainting]]
+*[[Paroxysmal nocturnal dyspnoea]]
-* [[Fatigue]]
+*Reduced [[exercise tolerance]]
-* [[Hemoptysis]] or frothy sputum
+*[[Fatigue]]
-* [[Nocturia]] or [[urination during the night]]
+*[[Tiredness]]
-* [[cough|Nocturnal cough]]
+* Increased time to recover after [[exercise]]
-* [[Orthopnea]] or [[sleeping on pillows]]
+*[[Ankle swelling]]
-* [[Palpitation]]s or [[extra heart beats]]
+| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Elevated [[jugular venous pressure]]
-* [[Paroxysmal nocturnal dyspnea]] or [[awakening at night with shortness of breath]]
+*[[Hepatojugular reflux]]
-* [[Shortness of breath]]
+*[[Third heart sound]] ([[gallop rhythm]])
-* [[Syncope]] or [[passing out]]
+*Laterally displaced [[apical impulse]]
-* [[Weakness]]
-* [[Wheezing]] or cardiac asthma
+|-
+! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF|Less typical symptoms}}
+! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Less specific signs}}
+|-
+| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Nocturnal cough]]
+*[[Wheezing]]
+*[[Bloated]] feeling
+*Loss of [[appetite]]
+*[[Confusion]] (especially in the [[elderly]])
+*[[Depression]]
+*[[Palpitation]]
+*[[Dizziness]]
+*[[Syncope]]
+*[[Bendopnea]]
+| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Weight gain]] (>2 kg/week)
+*[[Weight loss]] (in advanced [[HF]])
+*Tissue [[wasting]] ([[cachexia]])
+*[[Cardiac murmur]]
+*[[Peripheral oedema]] ([[ankle]], [[sacral]], [[scrotal]])
+*[[Pulmonary crepitations]]
+*[[Pleural effusion]]
+*[[Tachycardia]]
+*[[Irregular pulse]]
+*[[Tachypnoea]]
+*[[Cheyne-Stokes respiration]]
+*[[Hepatomegaly]]
+*[[Ascites]]
+*[[Cold extremities]]
+*[[Oliguria]]
+*Narrow [[pulse pressure]]
+|-
+|}
+{|
+! colspan="2" style="background: PapayaWhip;" align="center" + |The above table adopted from 2021 ESC Guideline
+|-
+|}<ref name="pmid34447992">{{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure |journal=Eur Heart J |volume=42 |issue=36 |pages=3599–3726 |date=September 2021 |pmid=34447992 |doi=10.1093/eurheartj/ehab368 |url=}}</ref>
-==Symptoms of Left Sided Congestive Heart Failure==
+===Symptoms of Left Sided Congestive Heart Failure===
 The left side pumps blood into the systemic circulation, while the right side pumps blood into the [[pulmonary circulation]]. Although left-sided heart failure will reduce forward [[cardiac output]] to the systemic circulation, the initial symptoms are often due to [[pulmonary congestion]]. In systolic dysfunction, the ejection fraction is decreased, leaving an abnormally elevated volume of blood in the [[left ventricle]]. In [[diastolic dysfunction]], [[left ventricular end-diastolic pressure]] will be high. This increase in volume or pressure backs up to the [[left atrium]] and then into the [[pulmonary vein]]s. Increased volume or pressure in the pulmonary veins impairs the normal drainage of the [[alveoli]] and favors the flow of fluid from the capillaries to the lung parenchyma, causing [[pulmonary edema]]. This impairs gas exchange and results in [[hypoxemia]]. Thus, left-sided heart failure often presents with respiratory symptoms including:
 *[[Dyspnea]]
@@ Line 37: / Line 89: @@
 *[[Wheezing]]
-==New York Heart Association Criteria (NYHA)==
+===New York Heart Association Criteria (NYHA)===
 The following criteria are often used to gauge the severity of heart failure:
@@ Line 47: / Line 99: @@
 *'''[[New york heart association functional classification#New York Heart Association Functional Classification (NYHA)|NYHA IV]]:''' Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency present at rest.
-==ACC/AHA 2009 Focused Update on Guidelines for the Diagnosis and Management of Chronic Heart Failure in the Adult- Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure (DO NOT EDIT)<ref name="Hunt"> Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12): e154-235. Epub 2005 Sep 13. PMID 16160202</ref><ref name="pmid19324967">Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19324967 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.] ''Circulation'' 119 (14):1977-2016. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192064 DOI:10.1161/CIRCULATIONAHA.109.192064] PMID: [http://pubmed.gov/19324967 19324967]</ref>==
-{|class="wikitable"
-|-
-| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
-|-
-| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' A thorough history and [[Congestive heart failure physical examination|physical examination]] should be obtained/performed in patients presenting with [[heart failure]] to identify cardiac and noncardiac disorders or behaviors that might cause or accelerate the development or progression of [[heart failure]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki>
-|-
-| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' A careful history of current and past use of [[alcohol]], illicit drugs, current or past standard or ''alternative therapies,'' and [[chemotherapy]] drugs should be obtained from patients presenting with [[heart failure]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki>
-|}
-==2009 ACC/AHA Focused Update on Guidelines for the Diagnosis and Management of Chronic Heart Failure in the Adult - Recommendations for the Serial Clinical Assessment of Patients Presenting With Heart Failure (DO NOT EDIT)<ref name="Hunt"> Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12): e154-235. Epub 2005 Sep 13. PMID 16160202</ref><ref name="pmid19324967">Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19324967 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.] ''Circulation'' 119 (14):1977-2016. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192064 DOI:10.1161/CIRCULATIONAHA.109.192064] PMID: [http://pubmed.gov/19324967 19324967]</ref>==
-{|class="wikitable"
-|-
-| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
-|-
-| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Careful history of current use of [[alcohol]], [[tobacco]], illicit drugs, ''alternative therapies,'' and [[chemotherapy]] drugs, as well as diet and [[sodium]] intake, should be obtained at each visit of a patient with [[heart failure]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki>
-|}
-==Vote on and Suggest Revisions to the Current Guidelines==
-*[[The Living Guidelines: Diagnosis and Management of Chronic Heart Failure | The CHF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]]
-==Guidelines Resources==
-*[http://circ.ahajournals.org/content/112/12/e154.full.pdf The ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult] <ref name="Hunt"> Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12): e154-235. Epub 2005 Sep 13. PMID 16160202</ref>
-*[http://content.onlinejacc.org/cgi/reprint/53/15/1343.pdf 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation] <ref name="pmid19324967">Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19324967 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.] ''Circulation'' 119 (14):1977-2016. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192064 DOI:10.1161/CIRCULATIONAHA.109.192064] PMID: [http://pubmed.gov/19324967 19324967]</ref>
 ==References==
 {{Reflist|2}}
+{{WikiDoc Help Menu}}
+{{WikiDoc Sources}}
+[[Category:Cardiology]]
 [[Category:Disease]]
-[[Category:Cardiology]]
 [[Category:Emergency medicine]]
+[[Category:Intensive care medicine]]
-{{WikiDoc Help Menu}}
+[[Category:Medicine]]
-{{WikiDoc Sources}}
+[[Category:Up-To-Date]]
+[[Category:Up-To-Date cardiology]]